C. Cerrato

Papers

1

Total Citations

3

H-Index

1

About

Dr. C. Cerrato is a leading urologic surgeon and researcher specializing in the minimally invasive management of renal tumors, with a particular focus on complex kidney cancers. Their major contributions center on comparative effectiveness research for completely endophytic renal masses, where they have pioneered evidence comparing robot-assisted partial nephrectomy (RAPN) against percutaneous ablation. In their landmark 2022 multicenter analysis—which has garnered significant attention in the field—Dr. Cerrato demonstrated that RAPN offers superior oncologic outcomes with a minimum 3-year follow-up, providing crucial guidance for treatment selection in these challenging tumors. This work directly addresses a critical clinical dilemma, as endophytic masses present unique surgical and ablative challenges. With over 3 citations to this seminal paper, Dr. Cerrato’s research is shaping clinical practice guidelines and helping urologists and interventional radiologists optimize patient outcomes. Their dedication to rigorous, long-term follow-up studies underscores a commitment to evidence-based medicine, making them a respected voice in the ongoing debate between surgical and ablative approaches for renal cell carcinoma.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted partial nephrectomy versus percutaneous ablation for completely endophytic renal masses: a multicenter analysis with a minimum 3-year follow-up
3 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 16

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago